Fingerprint
Dive into the research topics of 'Regorafenib dose-optimisation in patients with refractory metastatic colorectal cancer (ReDOS): a randomised, multicentre, open-label, phase 2 study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically